Alyeska Investment Group
ORTX

Alyeska Investment Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Alyeska Investment Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,699
Closed -$1.02M – 534
2019
Q1 		$1.02M Sell
5,699
-5,426
-49% -$816K 0.01% 318
2018
Q4 		$1.75M Buy
+11,125
New +$1.66M 0.03% 290

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Alyeska Investment Group's ORTX Position: Q2 2019 in Review

Alyeska Investment Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2019, closing a stake of 5,699 shares — an estimated $1.02M sold.

Alyeska Investment Group first reported a position in ORTX in Q4 2018 and held it in 2 quarters. The position peaked at $1.75M in Q4 2018. 68 funds tracked by Wall St. Rank hold ORTX as of Q2 2019.

  • Alyeska Investment Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 5,699 Orchard Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $1.02M.
  • Alyeska Investment Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
  • Alyeska Investment Group's Orchard Therapeutics plc American Depositary Shares position peaked at $1.75M in Q4 2018.
  • 68 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.